Related references
Note: Only part of the references are listed.Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients
Sou Hirose et al.
GYNECOLOGIC ONCOLOGY (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy
Yuya Yoshimoto et al.
GYNECOLOGIC ONCOLOGY (2020)
Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study
Kuniko Sunami et al.
CANCER SCIENCE (2019)
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Fabrice Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients
Keisuke Tsuclaida et al.
JOURNAL OF RADIATION RESEARCH (2019)
Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer
Yasuhiko Ebina et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs
Joakim Dillner et al.
VACCINE (2018)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55years of age
Tino F. Schwarz et al.
CANCER MEDICINE (2017)
Variant Review with the Integrative Genomics Viewer
James T. Robinson et al.
CANCER RESEARCH (2017)
Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
Patricia Mucci LoRusso
JOURNAL OF CLINICAL ONCOLOGY (2016)
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
Sherri Z. Millis et al.
JAMA ONCOLOGY (2016)
Morphological distribution of cervical and corpus uteri cancer from Cancer Incidence in Five Continents Vol. X
Megumi Hori et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013
Kota Katanoda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project
Megumi Hori et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis
L. Rodriguez-Carunchio et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2015)
Landscape of genomic alterations in cervical carcinomas
Akinyemi I. Ojesina et al.
NATURE (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Radical hysterectomy for FIGO stage IIB cervical cancer: Clinicopathological characteristics and prognostic evaluation
Takahiro Kasamatsu et al.
GYNECOLOGIC ONCOLOGY (2009)
Comparison of the Novel Human Papillomavirus 4 Auto-capillary Electrophoresis Test with the Hybrid Capture 2 Assay and with the PCR HPV Typing Set Test in the Detection of High-Risk HPV Including HPV 16 and 18 Genotypes in Cervical Specimens
Jin Hwa Hong et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Mutation of the PIK3CA oncogene in human cancers
B Karakas et al.
BRITISH JOURNAL OF CANCER (2006)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
WA Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
